Associated Papers
Relationship between single-nucleotide polymorphisms and cancer immunotherapy efficacy and toxicity: a systematic review.
Specchia M et al.
Frontiers in Oncology, 2025
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma.
Boutros A et al.
Archives of Dermatological Research, 2024
Investigation of PD-1 gene variants in patients with endometrial cancer: A case-control study.
Fattahi MJ et al.
Turkish Journal of Obstetrics and Gynecology, 2024
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors.
Boutros A et al.
Immuno-oncology Technology, 2023
Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F et al.
International Journal of Immunogenetics, 2020
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.
Wagner M et al.
Frontiers in Immunology, 2020
Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F et al.
International Journal of Immunogenetics, 2019
Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females.
Abo El-Khair SM et al.
Lupus, 2019
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
Santos N et al.
Annals of Hematology, 2018
Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort.
Soelberg K et al.
Multiple Sclerosis and Related Disorders, 2018
Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis?: A meta-analysis.
Zou Y et al.
Medicine, 2017
Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients.
Namavar Jahromi F et al.
Immunological Investigations, 2017
Association between PDCD1, CTLA4, and MECP2 gene polymorphisms and systemic lupus erythematosus in the Chinese Northern Han.
Dong HR et al.
Genetics and Molecular Research : Gmr, 2015
The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association, 2015
Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.
Dias FC et al.
Plos One, 2013
Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population.
Ming ZJ et al.
Rheumatology International, 2012
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population.
Liu X et al.
Rheumatology International, 2011
Genetic studies of systemic lupus erythematosus in Asia: where are we now?
Kim I et al.
Genes and Immunity, 2009
PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome.
Meng Q et al.
Molecular Vision, 2009
Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese.
Wang Q et al.
Archives of Dermatological Research, 2008
Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
Velázquez-Cruz R et al.
European Journal of Human Genetics : Ejhg, 2007
Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus.
Johansson M et al.
Arthritis and Rheumatism, 2005
A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.
Kong EK et al.
Arthritis and Rheumatism, 2005
Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population.
Yang Q et al.
Clinical and Experimental Rheumatology, 0
Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility.
do Canto LM et al.
Revista Brasileira De Reumatologia, 0